Basic Information
RNALocate ID: | RLID-D:11001451 |
RNA Symbol: | hsa-miR-19b-1-5p |
Localization: | Exosome |
RNA Information
RNA Name: | hsa-miR-19b-1-5p |
RNA ID: | miRBase:MIMAT0004491 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
Tissue/Cell Line: | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
Database: | EVmiRNA |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:11003570 | Exosome | Jurkat-derived T cell line (J77cl20) | 21505438 |
RLID-D:11000572 | Microvesicle | Mesenchymal stem cells |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-miR-19b-1-5p | Large cell neuroendocrine cancer | MNDR-E-MI-25517 |
MNDR | hsa-miR-19b-1-5p | Autism spectrum disorder | MNDR-E-MI-25518 |
MNDR | hsa-miR-19b-1-5p | Lymphoma | MNDR-E-MI-25519 |
MNDR | hsa-miR-19b-1-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-25520 |
MNDR | hsa-miR-19b-1-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-25521 |
MNDR | hsa-miR-19b-1-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-25522 |
MNDR | hsa-miR-19b-1-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-25523 |
MNDR | hsa-miR-19b-1-5p | Her2-receptor positive breast cancer | MNDR-E-MI-25524 |
MNDR | hsa-miR-19b-1-5p | Prostate cancer | MNDR-E-MI-25525 |
MNDR | hsa-miR-19b-1-5p | Gastric cancer | MNDR-E-MI-25526 |
MNDR | hsa-miR-19b-1-5p | Esophageal carcinoma | MNDR-E-MI-25527 |
MNDR | hsa-miR-19b-1-5p | Leukemia | MNDR-E-MI-25528 |
MNDR | hsa-miR-19b-1-5p | Parkinson disease | MNDR-E-MI-25529 |
MNDR | hsa-miR-19b-1-5p | Basal-like breast cancer | MNDR-E-MI-25530 |
MNDR | hsa-miR-19b-1-5p | Thyroid cancer | MNDR-E-MI-25531 |
MNDR | hsa-miR-19b-1-5p | Pancreatic cancer | MNDR-E-MI-25532 |
MNDR | hsa-miR-19b-1-5p | Rectum adenocarcinoma | MNDR-E-MI-25533 |
MNDR | hsa-miR-19b-1-5p | Colon cancer | MNDR-E-MI-25534 |
MNDR | hsa-miR-19b-1-5p | Colon adenocarcinoma | MNDR-E-MI-25535 |
MNDR | hsa-miR-19b-1-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-25536 |
MNDR | hsa-miR-19b-1-5p | Familial ovarian cancer | MNDR-E-MI-25537 |
MNDR | hsa-miR-19b-1-5p | Basal cell carcinoma | MNDR-E-MI-25538 |
MNDR | hsa-miR-19b-1-5p | Prostate adenocarcinoma | MNDR-E-MI-25539 |
MNDR | hsa-miR-19b-1-5p | Carcinoma ductal breast | MNDR-E-MI-25540 |
MNDR | hsa-miR-19b-1-5p | Glioblastoma | MNDR-E-MI-25541 |
MNDR | hsa-miR-19b-1-5p | Osteosarcoma | MNDR-E-MI-25542 |
MNDR | hsa-miR-19b-1-5p | Gastric adenocarcinoma | MNDR-E-MI-25543 |
MNDR | hsa-miR-19b-1-5p | Lung squamous cell carcinoma | MNDR-E-MI-25544 |
MNDR | hsa-miR-19b-1-5p | Lung adenocarcinoma | MNDR-E-MI-25545 |
MNDR | hsa-miR-19b-1-5p | Thyroid carcinoma | MNDR-E-MI-25546 |
MNDR | hsa-miR-19b-1-5p | Bladder urothelial carcinoma | MNDR-E-MI-25547 |
MNDR | hsa-miR-19b-1-5p | Pancreatic adenocarcinoma | MNDR-E-MI-25548 |
MNDR | hsa-miR-19b-1-5p | Kidney renal clear cell carcinoma | MNDR-E-MI-25549 |
MNDR | hsa-miR-19b-1-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-25550 |
MNDR | hsa-miR-19b-1-5p | Renal clear cell carcinoma | MNDR-E-MI-25551 |
MNDR | hsa-miR-19b-1-5p | Cholangiocarcinoma | MNDR-E-MI-25552 |
MNDR | hsa-miR-19b-1-5p | Lung small cell carcinoma | MNDR-E-MI-25553 |
MNDR | hsa-miR-19b-1-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-25554 |
MNDR | hsa-miR-19b-1-5p | Breast invasive carcinoma | MNDR-E-MI-25555 |
MNDR | hsa-miR-19b-1-5p | Hepatocellular carcinoma | MNDR-E-MI-25556 |
MNDR | hsa-miR-19b-1-5p | Familiar ovarian carcinoma | MNDR-E-MI-25557 |
MNDR | hsa-miR-19b-1-5p | Retinoblastoma | MNDR-E-MI-25558 |
MNDR | hsa-miR-19b-1-5p | Hodgkin lymphoma | MNDR-E-MI-25559 |
MNDR | hsa-miR-19b-1-5p | Colorectal cancer | MNDR-E-MI-25560 |
MNDR | hsa-miR-19b-1-5p | Breast cancer her3+ negative | MNDR-E-MI-25561 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | CASP8 | Homo sapiens | RR00279206 |
TOP